|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-11-6
|
|
pubmed:abstractText |
Insulin resistance (IR) and obesity are common features of the polycystic ovary syndrome (PCOS). Insulin-sensitizing agents have been shown to improve both reproductive and metabolic aspects of PCOS, but it remains unclear whether it is also beneficial in lean patients without pre-treatment IR. The aim of this study was to determine the influence of metformin on the clinical and biochemical parameters of PCOS irrespective of the presence of basal obesity and IR.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1479-683X
|
|
pubmed:author |
pubmed-author:BensonSvenS,
pubmed-author:DietzTiinaT,
pubmed-author:ElsenbruchSigridS,
pubmed-author:HahnSusanneS,
pubmed-author:JanssenOnno EOE,
pubmed-author:KimmigRainerR,
pubmed-author:LahnerHaraldH,
pubmed-author:MannKlausK,
pubmed-author:MoellerLars CLC,
pubmed-author:SchmidtMarkusM,
pubmed-author:TanSusanneS
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
157
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
669-76
|
|
pubmed:dateRevised |
2008-4-9
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.
|
|
pubmed:affiliation |
Division of Endocrinology, Department of Medicine, University Hospital of Essen Medical School, Hufelandstr. 55, 45122 Essen, Germany. susanne.tan@uk-essen.de
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
